Related LncRNAs
ID	lncRNA Name	Disease	Method	Sample	Expression pattern	Dysfunction type	Description	PMID	Source
EL0227	BANCR	hepatocellular carcinoma	quantitative real-time PCR (qRT-PCR), overexpression, downregulation, flow cytometry, and transwell invasion and migration assays	human hepatocellular carcinoma tissues	up-regulated	expression	BANCR may contribute to HCC initiation and progression and would be used as not only a novel prognostic marker but also a potential therapeutic target for this disease.	26758762
EL0310	CTBP1-AS	hepatocellular carcinoma	RT-qPCR	serum	N/A	N/A	high sensitivity and specificity for discriminating HCC from healthy controls and also from CHC patients	27113935
EL0575	HNF1A-AS1	hepatocellular carcinoma	N/A	HCC tissue and cell line	up-regulated	N/A	sponging tumor-suppressive hsa-miR-30b-5p (miR-30b) and de-repressing Bcl-2	27084450
EL0600	HULC	hepatocellular carcinoma	qPCR, Western blot, Luciferase reporter assay etc.	HCC tissue, cell lines (L-O2 cell line, L-O2-X)	up-regulated	expression	Our data show that an lncRNA, HULC, is responsible for the perturbations in circadian rhythm through upregulating circadian oscillator CLOCK in hepatoma cells, resulting in the promotion of hepatocarcinogenesis. Mechanistically, the complementary base pairing between HULC and the 5'untranslated region of CLOCK mRNA underlay the HULC-modulated expression of CLOCK, and the mutants in the complementary region failed to achieve the event.	25622901	Lnc2Cancer
EL0853	MALAT1	hepatocellular carcinoma	N/A	hepatocellular carcinoma (HCC) tissues	up-regulated	interaction	N/A	26352013
EL0861	MEG3	hepatocellular carcinoma	methylation specific PCR (MSP), qRT-PCR, RNA pulldown and western blot analysis, MTT assay, fluorescence microscopy and flow cytometry, improved MS2 biotin tagged RNA affinity purification method	hepatoma HepG2 and Huh7 cells	up-regulated	interaction	Ectopic expression of MEG3 inhibited hepatoma cell growth in a time-dependent manner, resulted in cell cycle arrest and induced apoptosis. Adenosine increases MEG3 expression by inhibition of DNA methylation and its antitumor effects is involved in MEG3 activation.	26647875
EL1363	TRERNA1	hepatocellular carcinoma	N/A	hepatoma cells	N/A	expression	miR-190a can silence treRNA post-transcriptionally. Suppression of treRNA by miR-190a led to significant changes of mesenchymal-epithelial transition markers and impaired migration and invasion capability of hepatoma cells.	26608035